Rocket Lab (NASDAQ:RKLB) reported Q1 revenue of $200.3M, beating estimates and issuing stronger-than-expected EBITDA guidance that sent shares up ~27.5%, while a new Iridium contract and raised price targets from Citizens and BofA underscore expanding non‑launch revenues and bullish analyst sentiment.
Previous Week Recap
- Rocket Lab Revenue Beats, Guidance Up: Rocket Lab (RKLB) Q1 revenue $200.3M, +63.5% YoY, 4.9% above estimates. Company issued stronger-than-expected next-quarter EBITDA guidance; shares jumped ~27.5% after the report.
- Rocket Lab Wins Iridium Contract: Rocket Lab (RKLB) won a contract vs. AST SpaceMobile to supply Iridium, potentially opening non-launch revenue like aviation safety and positioning and access to protected market segments.
- RKLB Price Targets Raised Equally: Two sell‑side firms raised Rocket Lab (RKLB) price targets: Citizens to $130 from $95; Bank of America to $115 from $105. Both kept positive ratings.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.